4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FDMT 4D Molecular Therapeutics

休市中 07-11 16:00:00 EDT

4.28

-0.07

-1.61%

盘后4.28

+0.000.00%

19:50 EDT

最高4.35	最低4.23	成交量18.33万
今开4.30	昨收4.35	日振幅2.64%
总市值1.98亿	流通市值1.51亿	总股本4,632万
成交额78.59万	换手率0.52%	流通股本3,539万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FDMT","market":"US","secType":"STK","nameCN":"4D Molecular Therapeutics","latestPrice":4.28,"timestamp":1752264000000,"preClose":4.35,"halted":0,"volume":183304,"hourTrading":{"tag":"盘后","latestPrice":4.28,"preClose":4.28,"latestTime":"19:50 EDT","volume":508,"amount":2179.93,"timestamp":1752277829511},"delay":0,"floatShares":35394870,"shares":46324642,"eps":-3.175547,"marketStatus":"休市中","change":-0.07,"latestTime":"07-11 16:00:00 EDT","open":4.3,"high":4.345,"low":4.23,"amount":785924.093689,"amplitude":0.026437,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.175547,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"listingDate":1607662800000,"exchange":"NASDAQ","adjPreClose":4.35,"preHourTrading":{"tag":"盘前","latestPrice":4.35,"preClose":4.35,"latestTime":"08:00 EDT","volume":51,"amount":221.85,"timestamp":1752235207878},"postHourTrading":{"tag":"盘后","latestPrice":4.28,"preClose":4.28,"latestTime":"19:50 EDT","volume":508,"amount":2179.93,"timestamp":1752277829511},"volumeRatio":0.7289204911743487,"impliedVol":2.4859,"impliedVolPercentile":0.9},"requestUrl":"/m/hq/s/FDMT","defaultTab":"news","newsList":[{"id":"2550541826","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大涨5.33%报4.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550541826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550541826?lang=zh_cn&edition=full","pubTime":"2025-07-10 00:14","pubTimestamp":1752077692,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日00时14分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速拉升5.33%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Nucana Plc涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为1574.31%、739.15%、616.04%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Nucana Plc，振幅分别为253.73%、154.98%、130.04%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710001452a69fc6e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710001452a69fc6e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","LENZ","FDMT"],"gpt_icon":0},{"id":"2549809555","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.07%报4.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549809555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549809555?lang=zh_cn&edition=full","pubTime":"2025-07-07 22:43","pubTimestamp":1751899415,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日22时43分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅跳水5.07%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Pelthos Therapeutics Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为4331.02%、1113.91%、821.89%，振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.，振幅分别为298.32%、93.67%、84.08%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707224335a43c1108&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707224335a43c1108&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","LENZ","FDMT"],"gpt_icon":0},{"id":"2546724934","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546724934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546724934?lang=zh_cn&edition=full","pubTime":"2025-06-25 22:19","pubTimestamp":1750861164,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日22时19分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速下挫5.00%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.82%。其相关个股中，Plus Therapeutics, Inc.、Seastar Medical Holding Corporation、内克塔治疗涨幅较大，Plus Therapeutics, Inc.、Seastar Medical Holding Corporation、Zyversa Therapeutics, Inc.较为活跃，换手率分别为945.02%、323.55%、218.93%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Seastar Medical Holding Corporation、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为137.04%、76.95%、53.06%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625221924a71d3714&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625221924a71d3714&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2545544502","title":"4D Molecular Therapeutics, Inc.盘中异动 急速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545544502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545544502?lang=zh_cn&edition=full","pubTime":"2025-06-23 23:50","pubTimestamp":1750693857,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日23时50分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速下挫5.08%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.涨幅较大，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Nucana Plc较为活跃，换手率分别为2500.32%、2025.01%、724.99%，振幅较大的相关个股有Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为273.41%、79.75%、71.02%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623235057a4b96dfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623235057a4b96dfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4539","FDMT","BK4139"],"gpt_icon":0},{"id":"2542348223","title":"4D Molecular Therapeutics, Inc.盘中异动 快速拉升6.32%报5.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542348223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542348223?lang=zh_cn&edition=full","pubTime":"2025-06-10 22:05","pubTimestamp":1749564347,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日22时05分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅上涨6.32%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Carisma Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大，Nucana Plc、Windtree Therapeutics, Inc.、Evogene Ltd.较为活跃，换手率分别为15882.19%、1986.86%、1043.78%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.、Nucana Plc，振幅分别为253.85%、191.40%、99.74%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610220547a4a20fb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610220547a4a20fb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","BK4139","FDMT"],"gpt_icon":0},{"id":"2541863589","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘急速拉升5.12%报4.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541863589","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541863589?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:39","pubTimestamp":1749217173,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时39分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速上涨5.12%。截至发稿，该股报4.11美元/股，成交量3.4877万股，换手率0.08%，振幅3.45%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213933a6fd4c6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213933a6fd4c6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2540570794","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大涨5.80%报3.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540570794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540570794?lang=zh_cn&edition=full","pubTime":"2025-06-02 23:42","pubTimestamp":1748878960,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日23时42分，4D Molecular Therapeutics, Inc.股票出现波动，股价大幅上涨5.80%。截至发稿，该股报3.83美元/股，成交量13.3945万股，换手率0.29%，振幅6.91%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.48%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602234240976e971a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602234240976e971a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4007","FDMT","LENZ"],"gpt_icon":0},{"id":"2537158349","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘急速跳水5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537158349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537158349?lang=zh_cn&edition=full","pubTime":"2025-05-23 22:52","pubTimestamp":1748011927,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日22时52分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速下挫5.14%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Imunon, Inc.、Dermata Therapeutics Inc C/Wts 、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Polyrizon Ltd.、Imunon, Inc.、Nucana Plc较为活跃，换手率分别为3174.76%、1863.80%、876.72%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Imunon, Inc.，振幅分别为208.33%、170.40%、81.83%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523225207a489d5a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523225207a489d5a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4007","LENZ","FDMT"],"gpt_icon":0},{"id":"2537937166","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大跌5.06%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537937166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537937166?lang=zh_cn&edition=full","pubTime":"2025-05-22 00:04","pubTimestamp":1747843463,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日00时04分，4D Molecular Therapeutics, Inc.股票出现波动，股价大幅跳水5.06%。截至发稿，该股报3.66美元/股，成交量13.4368万股，换手率0.29%，振幅6.36%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522000423a48705d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522000423a48705d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","FDMT","BK4007"],"gpt_icon":0},{"id":"2536582620","title":"4D Molecular Therapeutics, Inc.2025财年第一财季实现净利润-47.97百万美元，同比减少48.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536582620","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536582620?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497658,"startTime":"0","endTime":"0","summary":"5月18日，4D Molecular Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-47.97百万美元，同比减少48.06%；其中营业收入为14000.00美元，同比减少50.00%，每股基本收益为-0.86美元。从资产负债表来看，4D Molecular Therapeutics, Inc.总负债46.01百万美元，其中短期债务5.68百万美元，资产负债比为0.12，流动比率为0.13。机构评级：截至2025年5月18日，当前有10家机构对4D Molecular Therapeutics, Inc.目标价做出预测，其中目标均价为32.10美元，其中最低目标价为10.00美元，最高目标价为45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000550a6e2d973&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000550a6e2d973&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT"],"gpt_icon":0},{"id":"2536344163","title":"4D Molecular Therapeutics, Inc.盘中异动 快速拉升6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536344163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536344163?lang=zh_cn&edition=full","pubTime":"2025-05-17 02:44","pubTimestamp":1747421063,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日02时44分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速拉升6.09%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为5243.46%、3729.68%、1695.03%，振幅较大的相关个股有Affimed N.V.、Onconetix, Inc.、Vor Biopharma Inc.，振幅分别为466.98%、66.89%、66.82%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517024423a481393b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517024423a481393b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","BK4539","FDMT"],"gpt_icon":0},{"id":"2535714380","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大跌5.20%报3.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535714380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535714380?lang=zh_cn&edition=full","pubTime":"2025-05-14 23:08","pubTimestamp":1747235318,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日23时08分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速跳水5.20%。截至发稿，该股报3.10美元/股，成交量12.255万股，换手率0.26%，振幅7.34%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514230838975998b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514230838975998b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4007","LENZ","FDMT"],"gpt_icon":0},{"id":"2534791182","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘急速拉升5.13%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534791182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534791182?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:31","pubTimestamp":1747056701,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时31分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速上涨5.13%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Cytomx Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.涨幅较大，Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为283.67%、60.03%、58.48%，振幅较大的相关个股有Athira Pharma, Inc.、Imunon, Inc.、Gri Bio, Inc.，振幅分别为12.86%、10.00%、9.52%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213150a6dc4fdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213150a6dc4fdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","FDMT","BK4007"],"gpt_icon":0},{"id":"2534146479","title":"Chardan Capital：维持4D Molecular Therapeutics(FDMT.US)评级，由买入调整至买入评级, 目标价由28.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534146479","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534146479?lang=zh_cn&edition=full","pubTime":"2025-05-10 06:53","pubTimestamp":1746831217,"startTime":"0","endTime":"0","summary":"Chardan Capital：维持4D Molecular Therapeutics(FDMT.US)评级，由买入调整至买入评级, 目标价由28.00美元调整至25.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/10065350281681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","FDMT"],"gpt_icon":0},{"id":"2534451805","title":"高盛：维持4D Molecular Therapeutics(FDMT.US)评级，由买入调整至买入评级, 目标价由51.00美元调整至44.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534451805","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534451805?lang=zh_cn&edition=full","pubTime":"2025-05-10 02:03","pubTimestamp":1746813784,"startTime":"0","endTime":"0","summary":"高盛：维持4D Molecular Therapeutics(FDMT.US)评级，由买入调整至买入评级, 目标价由51.00美元调整至44.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/10020350281277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["FDMT","LENZ"],"gpt_icon":0},{"id":"2534245436","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘快速下跌5.25%报3.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534245436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534245436?lang=zh_cn&edition=full","pubTime":"2025-05-09 22:37","pubTimestamp":1746801479,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日22时37分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅下挫5.25%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Phathom Pharmaceuticals, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Nucana Plc、Polyrizon Ltd.、Pasithea Therapeutics Corp.较为活跃，换手率分别为1041.30%、139.80%、25.97%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Phathom Pharmaceuticals, Inc.，振幅分别为129.76%、56.12%、56.11%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509223800aa2c8948&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509223800aa2c8948&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","FDMT","BK4007","LENZ"],"gpt_icon":0},{"id":"2533306716","title":"4D Molecular Therapeutics, Inc.盘中异动 快速下挫5.04%报3.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533306716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533306716?lang=zh_cn&edition=full","pubTime":"2025-05-06 21:57","pubTimestamp":1746539870,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日21时57分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速跳水5.04%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.90%。其相关个股中，Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃，换手率分别为3620.10%、962.58%、256.49%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为107.74%、38.46%、30.65%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506215750aa2c8461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506215750aa2c8461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2533801695","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘急速下跌5.19%报3.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533801695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533801695?lang=zh_cn&edition=full","pubTime":"2025-05-05 22:01","pubTimestamp":1746453684,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日22时01分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速下跌5.19%。截至发稿，该股报3.57美元/股，成交量6.6005万股，换手率0.14%，振幅4.65%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050522012594ecf6d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050522012594ecf6d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FDMT","BK4007"],"gpt_icon":0},{"id":"2532824323","title":"4D Molecular Therapeutics, Inc.盘中异动 大幅拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532824323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532824323?lang=zh_cn&edition=full","pubTime":"2025-05-03 00:14","pubTimestamp":1746202481,"startTime":"0","endTime":"0","summary":"北京时间2025年05月03日00时14分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速拉升5.23%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Polyrizon Ltd.、Impact Biomedical, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Impact Biomedical, Inc.、Pmgc Holdings Inc.、Polyrizon Ltd.较为活跃，换手率分别为1243.87%、765.03%、623.18%，振幅较大的相关个股有Polyrizon Ltd.、Impact Biomedical, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为267.88%、119.72%、71.36%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503001441974d7b10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503001441974d7b10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2529822486","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大涨7.06%报3.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529822486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529822486?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:36","pubTimestamp":1745415376,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时36分，4D Molecular Therapeutics, Inc.股票出现波动，股价大幅拉升7.06%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。其相关个股中，Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Ensysce Biosciences, Inc.、Onconetix, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为3444.63%、19.92%、12.51%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Ocean Biomedical, Inc.，振幅分别为41.18%、29.61%、23.64%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213616a463fb77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213616a463fb77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","FDMT","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.4dmoleculartherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":-0.0183},{"period":"3month","weight":0.6274},{"period":"6month","weight":-0.2246},{"period":"1year","weight":-0.834},{"period":"ytd","weight":-0.2316}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"4D Molecular Therapeutics, Inc.于2015年3月11日根据特拉华州法律成立。该公司是一家领先的临床阶段生物制药公司，专注于通过针对特定疾病治疗进行优化的专有定制载体释放基因药物的全部潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.090662},{"month":2,"riseRate":0.2,"avgChangeRate":0.041082},{"month":3,"riseRate":0.6,"avgChangeRate":-0.023896},{"month":4,"riseRate":0.4,"avgChangeRate":-0.095608},{"month":5,"riseRate":0.6,"avgChangeRate":-0.116225},{"month":6,"riseRate":0.2,"avgChangeRate":-0.057799},{"month":7,"riseRate":0.8,"avgChangeRate":0.078113},{"month":8,"riseRate":0.25,"avgChangeRate":-0.049809},{"month":9,"riseRate":0.25,"avgChangeRate":-0.148039},{"month":10,"riseRate":0.25,"avgChangeRate":-0.11181},{"month":11,"riseRate":0.5,"avgChangeRate":0.477816},{"month":12,"riseRate":0.25,"avgChangeRate":0.044012}],"exchange":"NASDAQ","name":"4D Molecular Therapeutics","nameEN":"4D Molecular Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"4D Molecular Therapeutics,FDMT,4D Molecular Therapeutics股票,4D Molecular Therapeutics股票老虎,4D Molecular Therapeutics股票老虎国际,4D Molecular Therapeutics行情,4D Molecular Therapeutics股票行情,4D Molecular Therapeutics股价,4D Molecular Therapeutics股市,4D Molecular Therapeutics股票价格,4D Molecular Therapeutics股票交易,4D Molecular Therapeutics股票购买,4D Molecular Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}